PCPaul R. Carey

Paul R. Carey

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Paul R. Carey has a total of 73 co-authors. Here are the top co-authors by number of shared publications:

  • Christopher R. Bethel

    Research Service, Louis Stokes Cleveland Veterans Affairs Medical Center , Cleveland, Ohio 44106, United States

    5 shared publications
  • Marianne Pusztai-Carey

    Department of Biochemistry, Case Western Reserve University School of Medicine, 10900 Euclid Avenue, Cleveland Ohio 44106, United States

    5 shared publications
  • Robert A. Bonomo

    Research Service, Louis Stokes Cleveland Veterans Affairs Medical Center , Cleveland, Ohio 44106, United States

    5 shared publications
  • Hossein Heidari-Torkabadi

    Department of Biochemistry, Case Western Reserve University School of Medicine, 10900 Euclid Avenue, Cleveland Ohio 44106, United States

    4 shared publications
  • Marianne Pusztai-Carey

    Biochemistry Case Western Reserve University Cleveland Ohio USA

    4 shared publications
  • Tao Che

    Department of Biochemistry, Case Western Reserve University School of Medicine, 10900 Euclid Avenue, Cleveland Ohio 44106, United States

    4 shared publications

Latest Publications

  • Advances in applying Raman spectroscopy to the study of enzyme mechanisms

    by Paul Carey, Marianne Pusztai‐Carey

    This review sets out the progress over the past 50 years, mostly in the authors' laboratory, for Raman spectroscopy in defining the precise chemical changes driving enzyme‐mediated catalysis. The spectroscopy has been enabled by advances in computer, laser and optical technologies. Derek Long's generation (including the authors of this review) has been privileged to experience many of these changes. Here, we show how Raman can define individual molecular populations at work inside bacterial cells. In addition, several satellites have spun off the main theme. These include rapid reaction applications, drug screening, and RNA‐based enzymes. These are discussed briefly, and the reader can explore the details using the references given.


  • Measuring Drug-Induced Changes in Metabolite Populations of Live Bacteria: Real Time Analysis by Raman Spectroscopy

    by Paul R. Carey, Grant R. Whitmer, Michael J. Yoon, Michael N. Lombardo, Marianne Pusztai-Carey, Hossein Heidari-Torkabadi, Tao Che


  • Defining Molecular Details of the Chemistry of Biofilm Formation by Raman Microspectroscopy

    by Paul R. Carey, Blake R. Gibson, Jordan F. Gibson, Michael E. Greenberg, Hossein Heidari-Torkabadi, Marianne Pusztai-Carey, Sean T. Weaver, Grant R. Whitmer

    Two protocols that allow for the comparison of Raman spectra of planktonic cells and biofilm formed from these cells in their growth phase have been developed. Planktonic cells are washed and flash-frozen in Escherichia coli type K12 cells, which do not readily form biofilm, are compared to those for Staphylococcus epidermidis cells, which prolifically synthesize biofilm. For E. coli, the Raman spectra of the planktonic and biofilm samples are similar with the exception that the spectral signature of RNA, present in planktonic cells, could not be detected in biofilm. For S. epidermidis, major changes occur upon biofilm formation. In addition to the absence of the RNA features, new bands occur near 950 cm–1 and between 1350 and 1420 cm–1 that are associated with an increase in carbohydrate content. Unlike the case in E. coli biofilm, the intensity of G base ring modes is reduced in but A and T base ring signatures become more prominent. For S. epidermis in the biofilm’s amide III region, there is evidence of an increase in the level of β-sheet structure accompanied by a decrease in α-helical content. The presence of biofilm is confirmed by microscope-aided photography and, separately, by staining with methyl violet.


  • Large α‐helical movements observed in ternary crystals of RB69 DNA polymerase following nucleotide incorporation

    by Ioanna H. Antonopoulos, Shuangluo Xia, Thomas D. Christian, William H. Konigsberg, Paul R. Carey

    Raman difference spectroscopy is used to monitor the conformational changes associated with dNMP incorporation in single crystals of a RB69 DNA polymerase (RB69pol) ternary complex. An inactive crystal of L415G RB69pol exo‐ with a primer/template duplex and a cognate dATP was produced in the presence of Ca2+. The Raman spectrum of the crystallized complex was obtained using a Raman microscope. Phosphodiester bond formation is triggered by soaking in Mg2+. The Raman difference spectra [ie, (ternary complex + Mg2+)–(ternary complex with no Mg2+)] show that conformational changes are complete prior to the acquisition of the first Raman spectrum following magnesium incorporation into the crystal. Polyacrylamide gel electrophoresis experiments carried in parallel show that dNMP incorporation occurs rapidly in the crystal. The Raman data indicate that significant changes in protein amide features, tyrosine ring modes, and nucleic acid base backbone modes have occurred. Overall, they are dominated by the dichroic effect with the molecular groups changing orientation with respect to the laser beam following nucleotide incorporation. The amide I and amide III α‐helix features are unusually narrow and are assigned to movement of the P and N helices. These results demonstrate the ability of Raman spectroscopy to monitor conformational changes in proteins via dichroism. The Raman spectra and the gel electrophoresis support the hypothesis that the major spectroscopic changes are because of structural changes in the ternary complex crystal following correct dNMP incorporation. Copyright © 2015 John Wiley & Sons, Ltd.


  • “Mind the Gap”: Raman Evidence for Rapid Inactivation of CTX-M-9 β-Lactamase Using Mechanism-Based Inhibitors that Bridge the Active Site

    by Hossein Heidari-Torkabadi, Christopher R. Bethel, Zhe Ding, Marianne Pusztai-Carey, Richard Bonnet, Robert A. Bonomo, Paul R. Carey

    CTX-M β-lactamases are one of the fastest growing extended-spectrum β-lactamase (ESBL) families found in Escherichia coli rendering this organism extremely difficult to treat with β-lactam antibiotics. Although they are grouped in class A β-lactamases, the CTX-M family possesses low sequence identity with other enzymes. In addition, they have high hydrolytic activity against oxyimino-cephalosporins, despite having smaller active sites compared to other ESBLs in class A. Similar to most class A enzymes, most of the CTX-M β-lactamases can be inhibited by the clinical inhibitors (clavulanic acid, sulbactam, and tazobactam), but the prevalence of inhibitor resistance is an emerging clinical threat. Thus, the mechanistic details of inhibition pathways are needed for new inhibitor development. Here, we use Raman microscopy to study the CTX-M-9 inactivation reaction with the three commercially available inhibitors and compare these findings to the analysis of the S130G variant. Characterization of the reactions ...


  • New techniques in antibiotic discovery and resistance: Raman spectroscopy

    by Paul R. Carey, Hossein Heidari‐Torkabadi

    Raman spectroscopy can play a role in both antibiotic discovery and understanding the molecular basis of resistance. A major challenge in drug development is to measure the population of the drug molecules inside a cell line and to follow the chemistry of their reactions with intracellular targets. Recently, a protocol based on Raman microscopy has been developed that achieves these goals. Drug candidates are soaked into live bacterial cells and subsequently the cells are frozen and freeze‐dried. The samples yield exemplary (nonresonance) Raman data that provide a measure of the number of drug molecules within each cell, as well as details of drug–target interactions. Results are discussed for two classes of compounds inhibiting either β‐lactamase or dihydrofolate reductase enzymes in a number of Gram‐positive or Gram‐negative cell lines. The advantages of the present protocol are that it does not use labels and it can measure the kinetics of cell–compound uptake on the time scale of minutes. Spectroscopic interpretation is supported by in vitro Raman experiments. Studying drug–target interactions in aqueous solution and in single crystals can provide molecular level insights into drug–target interactions, which, in turn, provide the underpinnings of our understanding of data from bacterial cells. Thus, the applicability of X‐ray crystallographic–derived data to in‐cell chemistry can be tested.


  • Measuring Propargyl-Linked Drug Populations Inside Bacterial Cells, and Their Interaction with a Dihydrofolate Reductase Target, by Raman Microscopy

    by Hossein Heidari-Torkabadi, Tao Che, Michael N. Lombardo, Dennis L. Wright, Amy C. Anderson, Paul R. Carey

    We report the first Raman spectroscopic study of propargyl-linked dihydrofolate reductase (DHFR) inhibitors being taken up by wild type Escherichia coli, Klebsiella pneumoniae, and Staphylococcus aureus cells. A novel protocol is developed where cells are exposed to the fermentation medium containing a known amount of an inhibitor. At a chosen time point, the cells are centrifuged and washed to remove the extracellular compound, then frozen and freeze–dried. Raman difference spectra of the freeze–dried cells (cells exposed to the drug minus cells alone) provide spectra of the compounds inside the cells, where peak intensities allow us to quantify the number of inhibitors within each cell. A time course for the propargyl-linked DHFR inhibitor UCP 1038 soaking into E. coli cells showed that penetration occurs very quickly and reaches a plateau after 10 min exposure to the inhibitor. After 10 min drug exposure, the populations of two inhibitors, UCP 1038 and UCP 1089, were ∼1.5 × 106 molecules in each E. coli cell, ∼4.7 × 105 molecules in each K. pneumonia cell, and ∼2.7 × 106 in each S. aureus cell. This is the first in situ comparison of inhibitor population in Gram-negative and Gram-positive bacterial cells. The positions of the Raman peaks also reveal the protonation of diaminopyrimidine ring upon binding to DHFR inside cells. The spectroscopic signature of protonation was characterized by binding an inhibitor to a single crystal of DHFR.


  • Open Access

    Time-Resolved Raman and Polyacrylamide Gel Electrophoresis Observations of Nucleotide Incorporation and Misincorporation in RNA within a Bacterial RNA Polymerase Crystal

    by Ioanna H. Antonopoulos, Yuko Murayama, Brittany A. Warner, Shun-Ichi Sekine, Shigeyuki Yokoyama, Paul R. Carey

    The bacterial RNA polymerase (RNAP) elongation complex (EC) is highly stable and is able to extend an RNA chain for thousands of nucleotides. Understanding the processive mechanism of nucleotide addition requires detailed structural and temporal data for the EC reaction. Here, a time-resolved Raman spectroscopic analysis is combined with polyacrylamide gel electrophoresis (PAGE) to monitor nucleotide addition in single crystals of the Thermus thermophilus EC (TthEC) RNAP. When the cognate base GTP, labeled with 13C and 15N (*GTP), is soaked into crystals of the TthEC, changes in the Raman spectra show evidence of nucleotide incorporation and product formation. The major change is the reduction of *GTP’s triphosphate intensity. Nucleotide incorporation is confirmed by PAGE assays. Both Raman and PAGE methods have a time resolution of minutes. There is also Raman spectroscopic evidence of a second population of *GTP in the crystal that does not become covalently linked to the nascent RNA chain. When this population is removed by “soaking out” (placing the crystal in a solution that contains no NTP), there are no perturbations to the Raman difference spectra, indicating that conformational changes are not detected in the EC. In contrast, the misincorporation of the noncognate base, 13C- and 15N-labeled UTP (*UTP), gives rise to large spectroscopic changes. As in the GTP experiment, reduction of the triphosphate relative intensity in the Raman soak-in data shows that the incorporation reaction occurs during the first few minutes of our instrumental dead time. This is also confirmed by PAGE analysis. Whereas PAGE data show *GTP converts 100% of the nascent RNA 14mer to 15mer, the noncognate *UTP converts only ∼50%. During *UTP soak-in, there is a slow, reversible formation of an α-helical amide I band in the Raman difference spectra peaking at 40 min. Similar to *GTP soak-in, *UTP soak-in shows Raman spectoscopic evidence of a second noncovalently bound *UTP population in the crystal. Moreover, the second population has a marked effect on the complex’s conformational states because removing it by “soaking-out” unreacted *UTP causes large changes in protein and nucleic acid Raman marker bands in the time range of 10–100 min. The conformational changes observed for noncognate *UTP may indicate that the enzyme is preparing for proofreading to excise the misincorporated base. This idea is supported by the PAGE results for *UTP soak-out that show endonuclease activity is occurring.


  • Open Access

    Detecting a Quasi-stable Imine Species on the Reaction Pathway of SHV-1 β-Lactamase and 6β-(Hydroxymethyl)penicillanic Acid Sulfone

    by Tao Che, Elizabeth A. Rodkey, Christopher R. Bethel, Sivaprakash Shanmugam, Zhe Ding, Marianne Pusztai-Carey, Michael Nottingham, Weirui Chai, John D. Buynak, Robert A. Bonomo, et al.

    For the class A β-lactamase SHV-1, the kinetic and mechanistic properties of the clinically used inhibitor sulbactam are compared with the sulbactam analog substituted in its 6β position by a CH2OH group (6β-(hydroxymethyl)penicillanic acid). The 6β substitution improves both in vitro and microbiological inhibitory properties of sulbactam. Base hydrolysis of both compounds was studied by Raman and NMR spectroscopies and showed that lactam ring opening is followed by fragmentation of the dioxothiazolidine ring leading to formation of the iminium ion within 3 min. The iminium ion slowly loses a proton and converts to cis-enamine (which is a β-aminoacrylate) in 1 h for sulbactam and in 4 h for 6β-(hydroxymethyl) sulbactam. Rapid mix–rapid freeze Raman spectroscopy was used to follow the reactions between the two sulfones and SHV-1. Within 23 ms, a 10-fold excess of sulbactam was entirely hydrolyzed to give a cis-enamine product. In contrast, the 6β-(hydroxymethyl) sulbactam formed longer-lived acyl–enzyme intermediates that are a mixture of imine and enamines. Single crystal Raman studies, soaking in and washing out unreacted substrates, revealed stable populations of imine and trans-enamine acyl enzymes. The corresponding X-ray crystallographic data are consonant with the Raman data and also reveal the role played by the 6β-hydroxymethyl group in retarding hydrolysis of the acyl enzymes. The 6β-hydroxymethyl group sterically hinders approach of the water molecule as well as restraining the side chain of E166 that facilitates hydrolysis.


  • Open Access

    Following Drug Uptake and Reactions inside Escherichia coli Cells by Raman Microspectroscopy

    by Hossein Heidari Torkabadi, Christopher R. Bethel, Krisztina M. Papp-Wallace, Piet A. J. de Boer, Robert A. Bonomo, Paul R. Carey

    Raman microspectroscopy combined with Raman difference spectroscopy reveals the details of chemical reactions within bacterial cells. The method provides direct quantitative data on penetration of druglike molecules into Escherichia coli cells in situ along with the details of drug–target reactions. With this label-free technique, clavulanic acid and tazobactam can be observed as they penetrate into E. coli cells and subsequently inhibit β-lactamase enzymes produced within these cells. When E. coli cells contain a β-lactamase that forms a stable complex with an inhibitor, the Raman signature of the known enamine acyl–enzyme complex is detected. From Raman intensities it is facile to measure semiquantitatively the number of clavulanic acid molecules taken up by the lactamase-free cells during growth.